Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 153,440 shares.
Resverlogix Stock Down 9.1 %
The firm’s 50 day simple moving average is C$0.06 and its two-hundred day simple moving average is C$0.06. The stock has a market capitalization of C$13.85 million, a P/E ratio of -1.00 and a beta of 0.71.
Resverlogix (TSE:RVX – Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported C($0.03) earnings per share (EPS) for the quarter. As a group, equities research analysts expect that Resverlogix Corp. will post -0.22 earnings per share for the current year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
- Five stocks we like better than Resverlogix
- What is a Bond Market Holiday? How to Invest and Trade
- Oracle Announces Game-Changing News for the AI Industry
- Health Care Stocks Explained: Why You Might Want to Invest
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- How to Use the MarketBeat Stock Screener
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
